TY - JOUR
T1 - Raman Spectroscopy for Instant Bladder Tumor Diagnosis
T2 - System Development and In Vivo Proof-Of-Principle Study in Accordance with the European Medical Device Regulation (MDR2017/745)
AU - Latka, Ines
AU - Mogensen, Karin
AU - Knorr, Florian
AU - Kuzucu, Cansu
AU - Windirsch, Florian
AU - Sandic, Dragan
AU - Popp, Jürgen
AU - Hermann, Gregers G
AU - Schie, Iwan W
PY - 2024/9/23
Y1 - 2024/9/23
N2 - This work reports on an in vivo Raman-based endoscopy system, invaScope, enabling Raman measurements of healthy and tumor bladder tissue during an endoscopic procedure in the operating theatre. The presented study outlines the progression from the initial concept (validated through previously performed ex vivo studies) to the approval and implementation of a clinical investigational device according to the requirement within the framework of the European Medical Device Regulation (MDR2017/745). The study's primary objective was to employ the invaScope Raman system within the bladder, capturing in vivo spectroscopic Raman data followed by standard histo- and cytopathological examinations of urological tissue (considered the gold standard). The collected data were analyzed and correlated with histopathological findings post-procedure. Additionally, the study aimed to assess the feasibility of using diagnostic equipment, probes, and software for application in a clinical setting, evaluating usability aspects that are important during surgical procedures. This research represents a pivotal step toward advancing Raman spectroscopy for routine clinical use in characterizing bladder lesions.
AB - This work reports on an in vivo Raman-based endoscopy system, invaScope, enabling Raman measurements of healthy and tumor bladder tissue during an endoscopic procedure in the operating theatre. The presented study outlines the progression from the initial concept (validated through previously performed ex vivo studies) to the approval and implementation of a clinical investigational device according to the requirement within the framework of the European Medical Device Regulation (MDR2017/745). The study's primary objective was to employ the invaScope Raman system within the bladder, capturing in vivo spectroscopic Raman data followed by standard histo- and cytopathological examinations of urological tissue (considered the gold standard). The collected data were analyzed and correlated with histopathological findings post-procedure. Additionally, the study aimed to assess the feasibility of using diagnostic equipment, probes, and software for application in a clinical setting, evaluating usability aspects that are important during surgical procedures. This research represents a pivotal step toward advancing Raman spectroscopy for routine clinical use in characterizing bladder lesions.
UR - http://www.scopus.com/inward/record.url?scp=85205241706&partnerID=8YFLogxK
U2 - 10.3390/cancers16183238
DO - 10.3390/cancers16183238
M3 - Journal article
C2 - 39335209
SN - 2072-6694
VL - 16
JO - Cancers
JF - Cancers
IS - 18
M1 - 3238
ER -